Notes
2016 euros
Reference
Wisloff T, et al. Economic Evaluation of Direct-Acting Antivirals for Hepatitis C in Norway PharmacoEconomics : 2 Feb 2018. Available from: URL: https://doi.org/10.1007/s40273-017-0604-3
Rights and permissions
About this article
Cite this article
DAAs cost effective for treatment of hepatitis C in Norway. PharmacoEcon Outcomes News 796, 11 (2018). https://doi.org/10.1007/s40274-018-4685-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-018-4685-9